P110022S007

None

FDA Premarket Approval P110022 S007

This post-approval study has not been publically released by the fda. It may be a place-holder supplement number.

Pre-market Approval Supplement Details

DeviceP110022S007
Classification NameNone
Applicant
PMAP110022
SupplementS007

Supplemental Filings

Supplement NumberDateSupplement Type
P110022Original Filing
S028 2021-12-02 30-day Notice
S027 2018-10-26 Normal 180 Day Track No User Fee
S026 2018-10-09 30-day Notice
S025 2018-04-17 Real-time Process
S024 2017-10-11 Real-time Process
S023 2017-08-03 30-day Notice
S022 2017-07-06 Normal 180 Day Track
S021 2017-05-24 30-day Notice
S020 2016-12-07 Real-time Process
S019 2016-09-07 Normal 180 Day Track No User Fee
S018 2016-07-11 135 Review Track For 30-day Notice
S017 2016-02-16 30-day Notice
S016 2016-01-27 30-day Notice
S015 2016-01-27 135 Review Track For 30-day Notice
S014 2015-10-07 30-day Notice
S013 2014-10-16 Real-time Process
S012 2014-04-04 Real-time Process
S011 2013-07-19 Special (immediate Track)
S010
S009 2012-11-30 30-day Notice
S008 2012-08-31 Normal 180 Day Track
S007
S006 2012-02-29 30-day Notice
S005 2012-02-02 30-day Notice
S004 2012-02-02 30-day Notice
S003 2012-02-02 30-day Notice
S002 2012-01-31 135 Review Track For 30-day Notice
S001 2012-01-31 Normal 180 Day Track No User Fee

NIH GUDID Devices

Device IDPMASupp
07613336153932 P110022 022

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.